Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV)
- PMID: 11815612
- DOI: 10.1074/jbc.M110798200
Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV)
Abstract
We have investigated the interaction of bis(acetylacetonato)oxovanadium(IV) (VO(acac)(2)) with bovine serum albumin (BSA) by EPR and angle-selected electron nuclear double resonance, correlating results with assays of glucose uptake by 3T3-L1 adipocytes. EPR spectra of VO(acac)(2) showed no broadening in the presence of BSA; however, electron nuclear double resonance titrations of VO(acac)(2) in the presence of BSA were indicative of adduct formation of VO(acac)(2) with albumin of 1:1 stoichiometry. The influence of VO(acac)(2) on uptake of 2-deoxy-d-[1-(14)C]glucose by serum-starved 3T3-L1 adipocytes was measured in the presence and absence of BSA. Glucose uptake was stimulated 9-fold in the presence of 0.5 mm VO(acac)(2), 17-fold in the presence of 0.5 mm VO(acac)(2) plus 1 mm BSA, and 22-fold in the presence of 100 nm insulin. BSA had no influence on glucose uptake, on the action of insulin, or on glucose uptake in the presence of VOSO(4). The maximum insulin-mimetic effect of VO(acac)(2) was observed at VO(acac)(2):BSA ratios less than or equal to 1.0. Similar results were obtained also with bis(maltolato)oxovanadium(IV). These results suggest that the enhanced insulin-mimetic action of organic chelates of VO(2+) may be dependent on adduct formation with BSA and possibly other serum transport proteins.
Similar articles
-
The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.J Biol Inorg Chem. 2005 Dec;10(8):874-86. doi: 10.1007/s00775-005-0037-x. Epub 2005 Oct 19. J Biol Inorg Chem. 2005. PMID: 16235045
-
Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.Inorg Chem. 2000 Feb 7;39(3):406-16. doi: 10.1021/ic9905897. Inorg Chem. 2000. PMID: 11229556
-
Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.Metallomics. 2013 Jun;5(7):813-20. doi: 10.1039/c3mt00001j. Metallomics. 2013. PMID: 23576171
-
Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds.J Inorg Biochem. 2000 May 30;80(1-2):123-31. doi: 10.1016/s0162-0134(00)00048-9. J Inorg Biochem. 2000. PMID: 10885472 Review.
-
Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum.J Inorg Biochem. 2000 May 30;80(1-2):65-73. doi: 10.1016/s0162-0134(00)00041-6. J Inorg Biochem. 2000. PMID: 10885465 Review.
Cited by
-
A Spectroscopy Approach for the Study of the Interaction of Oxovanadium(IV)-Salen Complexes with Proteins.J Fluoresc. 2015 Jul;25(4):1141-9. doi: 10.1007/s10895-015-1604-3. Epub 2015 Jul 3. J Fluoresc. 2015. PMID: 26139532
-
The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.J Biol Inorg Chem. 2005 Dec;10(8):874-86. doi: 10.1007/s00775-005-0037-x. Epub 2005 Oct 19. J Biol Inorg Chem. 2005. PMID: 16235045
-
Vanadium Compounds with Antidiabetic Potential.Int J Mol Sci. 2023 Oct 27;24(21):15675. doi: 10.3390/ijms242115675. Int J Mol Sci. 2023. PMID: 37958659 Free PMC article. Review.
-
Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.J Biol Inorg Chem. 2007 Aug;12(6):843-53. doi: 10.1007/s00775-007-0239-5. Epub 2007 May 15. J Biol Inorg Chem. 2007. PMID: 17503093
-
Albumin and mammalian cell culture: implications for biotechnology applications.Cytotechnology. 2010 Jan;62(1):1-16. doi: 10.1007/s10616-010-9263-3. Epub 2010 Apr 6. Cytotechnology. 2010. PMID: 20373019 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous